Brief: Microport Scientific Says HY Rev Of Shanghai Microport Endovascular Medtech RMB714.4 Mln
26/08/2025 16:09
Aug 26 (Reuters) - Microport Scientific Corp 0853.HK: HY NET PROFIT ATTRIBUTABLE RMB314.6 MILLION FOR SHANGHAI MICROPORT ENDOVASCULAR MEDTECH (GROUP) HY REVENUE OF SHANGHAI MICROPORT ENDOVASCULAR MEDTECH RMB714.4 MILLION Further company coverage: 0853.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MicroPort Scientific
See all newsBrief: Microport Scientific Says Delay In Publication Of Interim Results
Brief: Microport Scientific Announces Delay In Publication Of 2026 Interim Results
Brief: Microport Scientific Says Shanghai Microport Endovascular Medtech Logs HY Revenue Of RMB793.95 Million
Brief: Microport Scientific Sees 12%-14% Y/Y Revenue Growth In Continuing Operations For HY
Brief: Microport Scientific Unit And Others To Sell 62% Of Shanghai Microport Orthopedics To Tinavi